Loading…
Based on limited metadata, this FDA Warning Letter issued to South Texas Botanicals on March 29, 2018, involves a botanical products company, though the specific product category and nature of the violations cannot be determined without access to the full letter text. The issuing office information is unavailable in the provided metadata. Without the detailed subject line and violation specifics, the regulatory concerns cannot be accurately characterized, though they likely relate to manufacturing, labeling, or marketing practices common to botanical product oversight.